These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 28098878)
1. Early growth response 3 inhibits growth of hepatocellular carcinoma cells via upregulation of Fas ligand. Zhang S; Xia C; Xu C; Liu J; Zhu H; Yang Y; Xu F; Zhao J; Chang Y; Zhao Q Int J Oncol; 2017 Mar; 50(3):805-814. PubMed ID: 28098878 [TBL] [Abstract][Full Text] [Related]
2. Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo. You N; Liu W; Wang T; Ji R; Wang X; Gong Z; Dou K; Tao K Oncol Rep; 2012 Dec; 28(6):2091-100. PubMed ID: 22993037 [TBL] [Abstract][Full Text] [Related]
3. Regulation of tumorigenesis and metastasis of hepatocellular carcinoma tumor endothelial cells by microRNA-3178 and underlying mechanism. Li W; Shen S; Wu S; Chen Z; Hu C; Yan R Biochem Biophys Res Commun; 2015 Aug; 464(3):881-7. PubMed ID: 26182877 [TBL] [Abstract][Full Text] [Related]
4. NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL-mediated extrinsic signaling pathway. Xu S; Shu P; Zou S; Shen X; Qu Y; Zhang Y; Sun K; Zhang J Cancer Med; 2018 Sep; 7(9):4701-4717. PubMed ID: 30085405 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma. Park JW; Lee YS; Kim JS; Lee SK; Kim BH; Lee JA; Lee NO; Kim SH; Hong EK J Cancer Res Clin Oncol; 2015 Nov; 141(11):1973-83. PubMed ID: 25842034 [TBL] [Abstract][Full Text] [Related]
6. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992 [TBL] [Abstract][Full Text] [Related]
7. Lamp2a is required for tumor growth and promotes tumor recurrence of hepatocellular carcinoma. Ding ZB; Fu XT; Shi YH; Zhou J; Peng YF; Liu WR; Shi GM; Gao Q; Wang XY; Song K; Jin L; Tian MX; Shen YH; Fan J Int J Oncol; 2016 Dec; 49(6):2367-2376. PubMed ID: 27840904 [TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA LINC00324 exerts protumorigenic effects on liver cancer stem cells by upregulating fas ligand via PU box binding protein. Gao J; Dai C; Yu X; Yin XB; Zhou F FASEB J; 2020 Apr; 34(4):5800-5817. PubMed ID: 32128906 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737. Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352 [TBL] [Abstract][Full Text] [Related]
10. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Zhao J; Zhang X; Shi M; Xu H; Jin J; Ni H; Yang S; Dai J; Wu M; Guo Y Hepatology; 2006 Jul; 44(1):205-15. PubMed ID: 16799960 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686. Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772 [TBL] [Abstract][Full Text] [Related]
12. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth. Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454 [TBL] [Abstract][Full Text] [Related]
13. Mir-765 promotes cell proliferation by downregulating INPP4B expression in human hepatocellular carcinoma. Xie BH; He X; Hua RX; Zhang B; Tan GS; Xiong SQ; Liu LS; Chen W; Yang JY; Wang XN; Li HP Cancer Biomark; 2016; 16(3):405-13. PubMed ID: 27062697 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway. Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259 [TBL] [Abstract][Full Text] [Related]
15. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway. Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461 [TBL] [Abstract][Full Text] [Related]
16. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma. Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560 [TBL] [Abstract][Full Text] [Related]
17. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo. Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196 [TBL] [Abstract][Full Text] [Related]
18. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2. Ou X; Lu Y; Liao L; Li D; Liu L; Liu H; Xu H Oncol Rep; 2015 Mar; 33(3):1264-74. PubMed ID: 25530218 [TBL] [Abstract][Full Text] [Related]
19. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway. Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916 [TBL] [Abstract][Full Text] [Related]
20. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway. Gu W; Li X; Wang J Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]